FindTrial
Sign In

Study on prediction of risk for Diabetes during pregnancy

Study on Gestational Diabetes Mellitus for risk prediction using Mass spectroscopy based proteomics and metabolomics.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/01/017119
Enrollment
30
Registered
2019-01-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O244- Gestational diabetes mellitus

Interventions

None listed

Sponsors

Osmania Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1PCOS women non pregnant and pregnant PCOS women with GDM 2.non PCOS GDM 3.healthy controls pregnant and non pregnant.

Exclusion criteria

Exclusion criteria: Pregestational diabetes Patients not willing to participate in the study

Design outcomes

Primary

MeasureTime frame
To search for biomarkers for predicting the risk of Gestational Diabetes Mellitus early .Timepoint: At the time of recruitment of participants—

Secondary

MeasureTime frame
â?¢ Establishment of Biomarker for diagnostic / early diagnostic of GDM and PCOS using body fluids especially serum/plasma, and saliva, by the help of high resolution mass spectrometry and quantitative proteomics and metabolomics. â?¢ Metabolomics biomarker: small molecules, amino acid, carbohydrate, lipid and peptide â?¢ Proteomics Biomarker: Protein â?¢ Validation of biomarker of GDM using Western blot and qPCR Timepoint: At the time of recruitment of participants—

Countries

India

Contacts

Public ContactK Neelaveni

Osmania Medical College

neelaveni1@yahoo.co.in9848131182

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026